<scp>Exploring the immunomodulatory impacts of blood manufacturing consolidation</scp>
Consolidation of blood production in Ontario was not associated with changes in rates of in-hospital mortality, respiratory failure, or organ dysfunction among transfusion recipients, but may be associated with a lower risk of sepsis. TRIM and the clinical impacts of changes to blood processing require further study.
Authors
- Nancy M. Heddle (ORCID: https://orcid.org/0000-0002-9671-3501)
- Summer Syed
- Amanda Kauffman (ORCID: https://orcid.org/0000-0003-4846-6806)
- Jason P. Acker (ORCID: https://orcid.org/0000-0002-1445-827X)
- Donald Arnold
- B. Rochwerg
- N. Li
- Y. Liu
- K. J. Lucier
- Shuoyan Ning
- Chris Hillis
- Michelle P. Zeller
Institutions
- University of Alberta (CA)
- University of Calgary (CA)
- University of Toronto (CA)
- McMaster University Medical Centre (CA)
- HalTech (CA)
- Impact (CA)
- Canadian Blood Services (CA)
- McMaster University (CA)
Publication Details
- Journal
- Transfusion
- Published
- 2026-02-02
- DOI
- https://doi.org/10.1111/trf.70088
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Canadian Blood Services